Elekta AB (publ)

Elekta AB (publ)

EKTAY

$5.19

Updated: 22/09/2026, 08:09:43

Market Cap
$1.98B
Sector
Healthcare
Industry
Medical - Devices
Country
SE
Stock valuation chart
One-year closing share-price history for EKTAY
Company Profile

Elekta AB (publ) is a global medical technology company dedicated to developing and delivering advanced clinical solutions for the treatment of cancer and brain disorders. Its comprehensive portfolio includes innovative radiotherapy systems such as the Elekta Unity MR-Linac, the Elekta Harmony linear accelerator, Elekta Infinity for diverse patient radiotherapy requirements, and the Elekta Synergy digital accelerator for advanced image-guided radiation therapy. Specific solutions like Versa HD are available for managing brain metastases. The company also supplies crucial treatment management software, automated and integrated quality assurance tools, and hardware and software for motion management. Further augmenting its oncology offerings, Elekta provides MOSAIQ Plaza for integrated multidisciplinary cancer care and Elekta Axis Cloud for managed hosting. Within brachytherapy, key products include the image-guided Elekta Studio, the mobile ImagingRing CT scanner, Oncentra Brachy for streamlining repetitive tasks, the Elekta Flexitron afterloader for precise workflow execution, and specialized applicators like Venezia and Geneva for cervical cancer treatment. For neurological conditions, Elekta offers a suite of advanced radiosurgery and neurosurgery solutions. This includes the Leksell Gamma Knife series – Icon for personalized radiation treatment, Perfexion for neurosurgical applications, and Lightning for accelerated procedures. Its neurosurgery product line features the Leksell Vantage Stereotactic System for intracranial interventions and the Leksell Stereotactic System for minimally invasive stereotactic neurosurgery. Founded in 1972, Elekta maintains its corporate headquarters in Stockholm, Sweden.

USD
OTC
CEO: Jakob Just-Bomholt
Employees: 4,102
https://www.elekta.com
Asset Summaries
Latest generated summaries for EKTAY

No summaries found.

Detailed business
Structured knowledge from the latest official annual filing.
No official annual filing has completed ingestion for this company yet. The filing worker processes major-index companies incrementally and never repeats a completed fiscal year.
Full company information
Latest profile, trading, valuation, and identifier data stored for EKTAY.
Share price
$5.19
Market cap
$1.98B
Exchange
OTC
Currency
USD
CEO
Jakob Just-Bomholt
Employees
4,102
IPO date
03/03/2009
Beta
1.076
Last dividend
$0.00
Day range
$5.17 – $5.22
52-week range
$4.35 – $6.93
1-day performance
0.39%
1-year performance
19.31%
Current drawdown (1Y)
-25.11%
CIK
N/A
CUSIP
28617Y101
ISIN
US28617Y1010
Created
07/12/2025, 03:45:22
Last update
22/09/2026, 08:09:43

Track Elekta AB (publ) with an AI analyst

See which prediction-market events move EKTAY, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.

Free forever to follow AlphaBrain’s AI strategies. No card required.